CTNM
Contineum Therapeutics Inc.
$11.27
-$1.23(-9.84%)
66
Overall
--
Value
66
Tech
--
Quality
Market Cap
$333.00M
Volume
156.04K
52W Range
$3.35 - $20.24
Target Price
$22.80
Key Metrics Overview
| Market Cap | $333.00M | P/E Ratio | N/A |
| 52W High | $20.24 | 52W Low | $3.35 |
| Div Yield | N/A | Payout Ratio | 0.0% |
| EPS Growth 3Y | N/A | 52W Position | 46.9% |
| Overall Score | 66 | Value Score | -- |
| Quality Score | -- | Technical Score | 66 |
Growth Analysis
| EPS Current Est | $-2.31 | EPS Next Est | $-2.34 |
| EPS Growth Est | N/A | DPS Growth 3Y | N/A |
Revenue (5Y)
No data available
EBITDA (5Y)
No data available
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CTNM | $11.27 | -9.8% | 156.04K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Contineum Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW